Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Giselle Saulnier Sholler"'
Autor:
Tyler Maser, Joseph Zagorski, Shannon Kelly, Anna Ostrander, Austin Goodyke, Abhinav Nagulapally, Jeffrey Bond, Yeonhee Park, Giselle Saulnier Sholler
Publikováno v:
Cancer Medicine, Vol 9, Iss 21, Pp 8144-8158 (2020)
Abstract Background Neuroblastoma (NB) is the most common extracranial solid tumor in infants and children, with amplification of the oncogene MYCN being a hallmark of high‐risk disease and poor prognosis. Although less frequent, overexpression of
Externí odkaz:
https://doaj.org/article/3ef5e01dd5a24d44b4b38f12291f29a3
Autor:
Ping Zhao, Jacob Hall, Mary Durston, Austin Voydanoff, Elizabeth VanSickle, Shannon Kelly, Abhinav B Nagulapally, Jeffery Bond, Giselle Saulnier Sholler
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0179948 (2017)
Medulloblastoma (MB) is the most common malignant brain tumor in children, accounting for nearly 20 percent of all childhood brain tumors. New treatment strategies are needed to improve patient survival outcomes and to reduce adverse effects of curre
Externí odkaz:
https://doaj.org/article/cadd038daed4440192e600b1ac3c282b
Autor:
Erin Murphy Trovillion, Meghan Michael, Cathryn C. Jordan, Lauren Brown, Katlin Phillips, Javier Oesterheld, Giselle Saulnier‐Sholler
Publikováno v:
Cancer Medicine, Vol 13, Iss 3, Pp n/a-n/a (2024)
Abstract Aim In this publication, we will share our experience of AE management, provide guidance for appropriate staffing, and the discuss the importance of patient education when treating patients with R/R HR neuroblastoma using naxitamab. Backgrou
Externí odkaz:
https://doaj.org/article/b10e441839c04027a47256527105a7db
Autor:
Rakesh K. Jain, Lore Gijsen, A. De Deene, Peter Carmeliet, William Ferguson, Jacqueline M. Kraveka, Kevin Bielamowicz, Michael S. Isakoff, Derek Hanson, Jennifer Michlitsch, Theodore W. Laetsch, Matija Snuderl, David Ebb, Genevieve Bergendahl, Dan G. Duda, Giselle Saulnier-Sholler
Purpose:Placental growth factor (PlGF) and its receptor neuropilin 1 are elevated in malignant embryonal tumors and mediate tumor progression by promoting cell proliferation, survival, and metastasis. TB-403 is a blocking monoclonal antibody against
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cb025ed6f7c58d85bba7cc89799184d
https://doi.org/10.1158/1078-0432.c.6532608
https://doi.org/10.1158/1078-0432.c.6532608
Autor:
Rakesh K. Jain, Lore Gijsen, A. De Deene, Peter Carmeliet, William Ferguson, Jacqueline M. Kraveka, Kevin Bielamowicz, Michael S. Isakoff, Derek Hanson, Jennifer Michlitsch, Theodore W. Laetsch, Matija Snuderl, David Ebb, Genevieve Bergendahl, Dan G. Duda, Giselle Saulnier-Sholler
Supplementary Data from A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e2971c220721b1e9553e12559094a33
https://doi.org/10.1158/1078-0432.22487913
https://doi.org/10.1158/1078-0432.22487913
Autor:
Giselle Saulnier-Sholler, Dan G. Duda, Genevieve Bergendahl, David Ebb, Matija Snuderl, Theodore W. Laetsch, Jennifer Michlitsch, Derek Hanson, Michael S. Isakoff, Kevin Bielamowicz, Jacqueline M. Kraveka, William Ferguson, Peter Carmeliet, A. De Deene, Lore Gijsen, Rakesh K. Jain
Publikováno v:
Clin Cancer Res
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 28, iss 18
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 28, iss 18
Purpose: Placental growth factor (PlGF) and its receptor neuropilin 1 are elevated in malignant embryonal tumors and mediate tumor progression by promoting cell proliferation, survival, and metastasis. TB-403 is a blocking monoclonal antibody against
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72bbbd1f502d78ebc6cff668bb44e34d
https://europepmc.org/articles/PMC9481695/
https://europepmc.org/articles/PMC9481695/
Autor:
Shannon Kelly, Jeffrey P. Bond, Austin Goodyke, Abhinav Nagulapally, Tyler Maser, Anna Ostrander, Giselle Saulnier Sholler, Joseph Zagorski, Yeonhee Park
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 21, Pp 8144-8158 (2020)
Cancer Medicine, Vol 9, Iss 21, Pp 8144-8158 (2020)
Background Neuroblastoma (NB) is the most common extracranial solid tumor in infants and children, with amplification of the oncogene MYCN being a hallmark of high‐risk disease and poor prognosis. Although less frequent, overexpression of MYC is si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2217c97eefef9d49b3aa39b0a2a030b
http://europepmc.org/articles/PMC7643634
http://europepmc.org/articles/PMC7643634
Autor:
Faith Cisneros, Austin Christofferson, Deanna Mitchell, Jawhar Rawwas, Don E Eslin, Randal K. Wada, Javier Oesterheld, Genevieve Bergendahl, Xinyu Wen, Jun S. Wei, Hue V. Reardon, Tyler Izatt, Jeffrey M. Trent, William Roberts, William P.D. Hendricks, Virginia L Harrod, Karl Dykema, Sara Nasser, Sara A. Byron, Elizabeth VanSickle, Bryce Turner, Jacqueline M. Kraveka, Peter E. Zage, Alison Roos, Apurva M. Hegde, Valerie I. Brown, Kathleen A. Neville, Albert Cornelius, Jonathan J Keats, Szabolcs Szelinger, Rebecca F. Halperin, Michael S. Isakoff, William S. Ferguson, Daniel Enriquez, Javed Khan, Abhinav Nagulapally, Jeffrey P. Bond, Hsien-Chao Chou, Giselle Saulnier Sholler
Publikováno v:
Cancer Res
Cancer research, vol 81, iss 23
Cancer research, vol 81, iss 23
Children with treatment-refractory or relapsed (R/R) tumors face poor prognoses. As the genomic underpinnings driving R/R disease are not well defined, we describe here the genomic and transcriptomic landscapes of R/R solid tumors from 202 patients e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd22240428073933d700f802c6b99e5d
https://pubmed.ncbi.nlm.nih.gov/34610968
https://pubmed.ncbi.nlm.nih.gov/34610968
Autor:
Jawhar Rawwas, Kristine Broglio, Jacqueline M. Kraveka, Giselle Saulnier Sholler, Elizabeth Lorenzi, William Roberts, Don Eslin, Jessica Foley, Peter E. Zage, Maria Rich, Valerie I. Brown, Genevieve Bergendahl, Deanna Mitchell, Elizabeth C. Lewis, Randal K. Wada, William S. Ferguson, Donald A. Berry, Javier Oesterheld
Publikováno v:
International Journal of Cancer
Neuroblastoma is a sympathetic nervous system tumor, primarily presenting in children under 6 years of age. The long‐term prognosis for patients with high‐risk neuroblastoma (HRNB) remains poor despite aggressive multimodal therapy. This report p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e8bd2a53065372065b04a4295bf0a32
https://pubmed.ncbi.nlm.nih.gov/32391579
https://pubmed.ncbi.nlm.nih.gov/32391579
Autor:
Zachary Brownlee, Jeffrey P. Bond, Izhar Singh Batth, Shulin Li, Jing Wang, Arun Satelli, Abhisek Mitra, Giselle Saulnier Sholler, Long Dao, Heming Li, Hyangsoon Noh, Jonathan Gill, Shouhao Zhou, Sofia Yi
Publikováno v:
Int J Cancer
Neuroblastoma (NB) is a deadly childhood disease that carries a 50% chance of relapse for anyone in remission and similar level of 5-year survival. We investigated the value of our proprietary approach – cell surface vimentin (CSV) positive circula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2979504bdde683668d6488fc23fdddee
https://pubmed.ncbi.nlm.nih.gov/33319927
https://pubmed.ncbi.nlm.nih.gov/33319927